CUA Educational Content

The Radioligand Therapy (RLT) Revolution in Prostate Cancer: Is Canada Ready?

Featuring: Kim Chi, Frédéric Pouliot, Stephan Probst


  • What is RLT, and what RLT therapies are under investigation in this space?
  • Requirements to implement RLT across Canada.
  • Existing gaps in infrastructure for RLT implementation and how these can be bridged to ensure access to patients from coast to coast.


This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.

This program has received financial support from Advanced Accelerator Applications: A Novartis Company in the form of an educational grant.